Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCK | P35557 | 10/20 | 0.37 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.35 |
| ▸ | IGF1R | P08069 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | MTOR | P42345 | 1/20 | 0.32 |
| ▸ | TYK2 | P29597 | 1/20 | 0.32 |
| ▸ | AURKA | O14965 | 2/20 | 0.32 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.31 |
| ▸ | HCK | P08631 | 1/20 | 0.30 |
| ▸ | BTK | Q06187 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL255633 | 0.78 | NTRK1 (0.52) | TYK2AURKAAURKB | |
| SCHEMBL15367101 | 0.76 | ABCG2 (0.38) | KDRPIK3CA | |
| SCHEMBL15366826 | 0.75 | CCR4 (0.36) | EGFRKDR | |
| SCHEMBL159775 | 0.73 | GSK3A (0.49) | LRRK2IGF1REGFRKDRAURKA | |
| SCHEMBL162812 | 0.71 | CYP1A2 (0.39) | EGFRKDR | |
| SCHEMBL15366436 | 0.71 | CYP1A2 (0.39) | EGFRKDR | |
| SCHEMBL15366895 | 0.68 | BUB1 (0.38) | AURKAAURKBBTK | |
| SCHEMBL23794877 | 0.65 | POLB (0.47) | GCKLRRK2IGF1R | |
| SCHEMBL174448 | 0.63 | HTR6 (0.38) | EGFRKDRPIK3CA | |
| SCHEMBL15366576 | 0.63 | MAPK14 (0.35) | EGFRPIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2663553-A2 | QUINOLINE AND ISOQUINOLINE COMPOUNDS AND METHODS OF USE THEREOF | Ambit Biosciences Corporation (US) | 2013-11-20 | — | — | EP | disclosed |
| WO-2012030944-A2 | QUINOLINE AND ISOQUINOLINE COMPOUNDS AND METHODS OF USE THEREOF | AMBIT BIOSCIENCES CORPORATION (US) | 2012-03-08 | — | — | WO | disclosed |